MIR514B

Across TCGA pan-cancer cohorts, MIR514B RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MIR514B data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR514B RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR514B expression acts as an unfavorable survival marker, although some lineages such as KIRC and COAD show a favorable association.

KIRC, LUAD, and BRCA are the cancer types where MIR514B RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.711	0.550	<.001	158	view →
LUAD	DFS	Tertile	III,IV	0.036	0.673	<.001	63	view →
BRCA	OS	Tertile	All	0.136	0.578	.013	36	view →
HNSC	OS	Tertile	III,IV	0.147	0.687	<.001	36	view →
COAD	OS	Tertile	All	0.925	0.743	.006	31	view →
LIHC	DFS	Tertile	II,III,IV	0.475	0.200	.041	9	view →
KIRP	DFS	Quartile	All	1.000	0.646	.027	8	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

MIR514B–KIRC (DFS)

Open the KIRC breakdown →